Dapagliflozin on Volume Vascular Outcomes.

NCT04869124 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure，Congestive

Interventions

DRUG: Dapagliflozin
DRUG: Placebo

Sponsor

Frank Ruschitzka

Collaborators

[object Object]